0.24+0.06 and 0.47+0.10, at 1 hr and 28 days, respectively). We conclude that CEU with microbubbles targeted for endothelial a,-in&grins can be used to non-invasively assess anglogenic responses in skeletal muscle. These results suggest that targeted CEU imaging of endothelial markers of angiogenesis may potentially be used for assessing intrinsic and therapeutic angiogenesis prior to changes tn perfusion.
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BACKGROUND:
Although perlluorocarbon containing albumin microbubbles (PESDA) can bind large quantities of antlsense (AS) to the c-myc protooncogene (anti-c-myc) which promotes intimal hyperpasia. it is unknown how much c-myc synthesis within the intracoronary (IC) stent or balloon injury is actually suppressed by this intravenous (IV) targeting technique in the early period following vascular injury. To examine this, we parformed high phase liquid chromatography of AS to c-myc uptake and Western Blot studies of c-myc protein synthesis in coronary arteries from eight pigs 90 minutes following IC stent and balloon injury (two vessels per pig). Pigs were treated with either direct IC antic-myc (4 milligrams), or the same dose of anti-c-myc IV bound or unbound to PESDA. IV PESDA containing anti-c-myc was given in the presence or absence of transthoracic 1 megahertz ultrasound (TTU) (pulsed wave at 0.6 W/cm?. RESULTS: C-myc protein synthesis in the injured coronary arteries (normalized for control vessels) was significantly lower when pigs were given IV anti-c-myc bound to PESDA irrespective of whether TTU was concomitantly delivered (TABLE) . Suppression of c-myc synthesis was comparable to direct IC injection. CONCLUSION: These data confirm that simply binding anti-c-myc to IV PESDA is a non-invasive method of targeting therapeutic genes to selective sites of IC balloon or stent injury and suppressing the formation of the c-myc protooncogene which mediates intimal hyperplasia and restenosis. 
802-3

Improvement in Epicardial Recanalization Rates With Transthoracic Therapeutic Ultrasound and Intravenous Microbubbles Containing Ligands Which Attach to the Glycoprotein Ilb/llla Receptor on Activated Platelets
Thomas R. Porter, Joseph Oberdorfer. Lucia Venneri, John Lof. Feng Xie, University of Nebraska Medical Center, Omaha, NE BACKGROUND: Intravenous (IV) perfluorocarbon containing microbubbles (PCMB) and transthoracic ultrasound (TrU) could potentially be used to improve epicardial recanalization rates (ERR) following acute coronary thrombotic occlusion. One limitation with this method is that inadequate PCMB reach the occluded coronary thrombus (CT) following IV injection. We hypothesized that attaching a ligand to the PCMB which binds to activated platelets within the CT would increase microbubble concentration at the site of the CT and enhance cavitation-induced lysis. Accordingly, we compared ERR following acute left circumflex thrombotic occlusion I" 50 pigs who were randomized to receive either IV tissue plasmlnogen activator (TPA) alone, versus IV TPA in combination with TTU and unlabelled IV PCMB (PESDA); or TrlJ with IV PCMB containing 50 u/kg of Eptifabitide (E-P&DA). TTU was intermittent 1 Megahertz at 1.5 Watt&+. Recanalization was assessed angiographically at 60 minutes following treatment. RESULTS: Activated clotting times were not different following any of the treatments. However, the Figure  demonstrates that ERR mcreased from ~20% with TPA alone to 60% with IV TPA and IV E-PESDA combined with TTU. CONCLUSION: These data indicate that IV E-PESDA can be used to increase delivery of microbubbles to acute coronary thrombotic occlusions and improve ultrasound-directed recanalization of the infarct related artery.
We have previously shown that ultrasound targeted microbubble destruction (UTMD) can augment expression of an adenoviral reporter in the heart. We now show that this method can selectively deliver transgenes to two organs that are particularly inaccessible to non-invasive strategies (pancreas and brain) and can be extended to plasmid vectors. Recombinant adenoviruses or plasmids containing expression constructs of beta-galactosidase and luciferase wars incorporated into albumin-coated perfluoropropane-filled microbubbles during their preparation. These bubbles were infused into the internal jugular vein of rats and destroyed with ultrasound while passing through the target organ.
Organs were harvested after 4 days and analyzed for reporter gene activity. Luciferase activity in organs targeted with adenovirus was 104 times higher than in control organs. However, liver activity was even higher. Histological examination revealed transgenederived beta-galactosidase activity in subsets of brain neurons and pancreatic islets.
Luciferase transfection with plasmids showed highly specific gene expression in the heart, lo-fold lower than obtained with adenovirus, but with negligible activity in liver (figure) . We conclude that ultrasound targeted microbubble destruction can markedly Improve the range and specificity of gene delivery. This technique heralds a new class of strategies for non-invasive gene therapy
